FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Sheremata

Research Profile

Disorders

Anatomy

Procedures

Cell Migration Inhibition

Concepts & Ideas

Magnetic Resonance Imaging

Chemicals & Drugs

Co-author Network

Publications

TOP 3
William A Sheremata; Leticia Tornes
Multiple sclerosis and the spinal cord.
Nida Usmani; Gurdesh Bedi; Byron Lam; William A Sheremata
Association between paroxysmal tonic spasms and neuromyelitis optica.
Gurdesh S Bedi; Andrew D Brown; Silvia Delgado; Byron Lam; Nida Usmani; William A Sheremata
Impact of rituximab on relapse rate and disability in neuromyelitis optica.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Sheremata (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: William A Sheremata; Leticia Tornes
Multiple sclerosis and the spinal cord.
Neurologic clinics 2013;31(1):55-77.
2012: Nida Usmani; Gurdesh Bedi; Byron Lam; William A Sheremata
Association between paroxysmal tonic spasms and neuromyelitis optica.
Archives of neurology 2012;69(1):121-4.
2011: Gurdesh S Bedi; Andrew D Brown; Silvia Delgado; Byron Lam; Nida Usmani; William A Sheremata
Impact of rituximab on relapse rate and disability in neuromyelitis optica.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(10):1225-30.
2010: Silvia Delgado; William A Sheremata; Andrew D Brown; Micheline McCarthy
Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports.
Journal of neurovirology 2010;16(3):249-53.
2010: Anish Thomas; Raisa Perzova; Lynn Abbott; Patricia Benz; Michael J Poiesz; Syamalima Dube; Thomas Loughran; Jorge Ferrer; William A Sheremata; Jordan Glaser; Matilde Leon-Ponte; Bernard J Poiesz
LGL leukemia and HTLV.
AIDS research and human retroviruses 2010;26(1):33-40.
2009: Silvia Delgado; Sheila Baez; Carlos Singer; Cenk Sengun; William A Sheremata; Spiridon Papapetropoulos
Parkinsonism/dystonia syndrome secondary to multiple sclerosis with anti-basal-ganglia antibodies.
Movement disorders : official journal of the Movement Disorder Society 2009;24(2):309-11.
2008: Khema R Sharma; Daniela Saadia; Alicia G Facca; Rita Bhatia; Doraiswami Ayyar; William A Sheremata
Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
Journal of clinical neuromuscular disease 2008;9(4):385-96.
2008: William A Sheremata; Wenche Jy; Lawrence L Horstman; Yeon S Ahn; J Steven Alexander; Alireza Minagar
Evidence of platelet activation in multiple sclerosis.
Journal of neuroinflammation 2008;5():27.
2006: Silvia Delgado; William A Sheremata
The role of CD4+ T-cells in the development of MS.
Neurological research 2006;28(3):245-9.
2006: William A Sheremata; Wenche Jy; Silvia Delgado; Alireza Minagar; Jerry McLarty; Yeon S Ahn
Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis.
Journal of neuroinflammation 2006;3():23.
2005: Paul O'Connor; David Miller; Katherine Riester; Minhua Yang; Michael A Panzara; Catherine Dalton; Katherine A Miszkiel; OA Khan; George Rice; William A Sheremata
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(5):568-72.
2005: William A Sheremata; Alireza Minagar; J Steven Alexander; Timothy Vollmer
The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications.
CNS drugs 2005;19(11):909-22.
2004: Wenche Jy; Alireza Minagar; Joaquin J Jimenez; William A Sheremata; Lucia M Mauro; Lawrence L Horstman; Carlos Bidot; Yeon S Ahn
Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis.
Frontiers in bioscience : a journal and virtual library 2004;9():3137-44.
2004: Paul W O'Connor; A Goodman; Allison J Willmer-Hulme; Michele A Libonati; Luanne M Metz; R S Murray; William A Sheremata; Timothy Vollmer; L A Stone
Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects.
Neurology 2004;62(11):2038-43.
2003: David H Miller; OA Khan; William A Sheremata; Lance D Blumhardt; G P A Rice; Michele A Libonati; Allison J Willmer-Hulme; Catherine M Dalton; Katherine A Miszkiel; Paul W O'Connor
A controlled trial of natalizumab for relapsing multiple sclerosis.
The New England journal of medicine 2003;348(1):15-23.
2002: Alireza Minagar; William A Sheremata; William J Weiner
Transient movement disorders and multiple sclerosis.
Parkinsonism & related disorders 2002;9(2):111-3.
2002: George W Lowis; William A Sheremata; Alireza Minagar
Epidemiologic features of HTLV-II: serologic and molecular evidence.
Annals of epidemiology 2002;12(1):46-66.
2001: Alireza Minagar; William A Sheremata; Ronald J Tusa
Perverted head-shaking nystagmus: a possible mechanism.
Neurology 2001;57(5):887-9.
2001: Alireza Minagar; Wenche Jy; Joaquin J Jimenez; William A Sheremata; Lucia M Mauro; WW Mao; Lawrence L Horstman; Yeon S Ahn
Elevated plasma endothelial microparticles in multiple sclerosis.
Neurology 2001;56(10):1319-24.
2000: Alireza Minagar; William A Sheremata
Glossopharyngeal neuralgia and MS.
Neurology 2000;54(6):1368-70.
1999: William A Sheremata; Timothy Vollmer; L A Stone; Allison J Willmer-Hulme; M Koller
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
Neurology 1999;52(5):1072-4.
1999: George W Lowis; William A Sheremata; P R Wickman; S Dube; K Dube; Bernard J Poiesz
HTLV-II risk factors in Native Americans in Florida.
Neuroepidemiology 1999;18(1):37-47.
1997: George W Elgart; William A Sheremata; Yeon S Ahn
Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum.
Journal of the American Academy of Dermatology 1997;37(4):553-8.
1997: Patricia W Nance; William A Sheremata; S G Lynch; T Vollmer; S Hudson; G S Francis; P O'Connor; Jeffrey A Cohen; R T Schapiro; Ruth H Whitham; Michele K Mass; J W Lindsey; K Shellenberger
Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis.
Archives of neurology 1997;54(6):731-6.
1996: D Squillacote; M Martinez; William A Sheremata
Natural alpha interferon in multiple sclerosis: results of three preliminary series.
The Journal of international medical research 1996;24(3):246-57.
1995: William A Sheremata; J R Taylor; George W Elgart
Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b.
The New England journal of medicine 1995;332(23):1584.
1995: William J Harrington; A Ucar; P Gill; S Snodgrass; William A Sheremata; Lisa Cabral; M Rabin; Gerald E Byrne; J Berger; W Voight
Clinical spectrum of HTLV-I in south Florida.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;8(5):466-73.
1994: Patricia W Nance; J Bugaresti; K Shellenberger; William A Sheremata; Alberto Martinez-Arizala
Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
Neurology 1994;44(11 Suppl 9):S44-51; discussion S51-2.
1993: William A Sheremata; D Benedict; D C Squilacote; A Sazant; E DeFreitas
High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy.
Neurology 1993;43(10):2125-9.
1993: William A Sheremata; William J Harrington; P A Bradshaw; Steven K H Foung; S P Raffanti; J R Berger; S Snodgrass; L Resnick; B J Poiesz
Association of '(tropical) ataxic neuropathy' with HTLV-II.
Virus research 1993;29(1):71-7.
1993: William J Harrington; William A Sheremata; Brian Hjelle; D K Dube; P Bradshaw; Steven K H Foung; S Snodgrass; G Toedter; Lisa Cabral; B Poiesz
Spastic ataxia associated with human T-cell lymphotropic virus type II infection.
Annals of neurology 1993;33(4):411-4.
1992: William A Sheremata; J R Berger; William J Harrington; Doraiswami Ayyar; M Stafford; E DeFreitas
Human T lymphotropic virus type I-associated myelopathy. A report of 10 patients born in the United States.
Archives of neurology 1992;49(11):1113-8.
1992: Paul Brown; Lev G Goldfarb; W R McCombie; A Nieto; D Squillacote; William A Sheremata; B W Little; M S Godec; CJ Gibbs; D Carleton Gajdusek
Atypical Creutzfeldt-Jakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene.
Neurology 1992;42(2):422-7.
1992: Lawrence Honig; R Eugene Ramsay; William A Sheremata
Event-related potential P300 in multiple sclerosis. Relation to magnetic resonance imaging and cognitive impairment.
Archives of neurology 1992;49(1):44-50.
1992: J R Berger; CS Tornatore; Eugene O Major; Jocelyn Bruce-Gregorios; Paul Shapshak; M Yoshioka; S Houff; William A Sheremata; G F Horton; Howard Landy
Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy.
Annals of neurology 1992;31(1):34-8.
1991: William J Harrington; William A Sheremata; S R Snodgrass; S Emerson; S Phillips; J R Berger
Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol.
AIDS research and human retroviruses 1991;7(12):1031-4.
1991: Fred F Telischi; L R Grobman; William A Sheremata; M Apple; R Ayyar
Hemifacial spasm. Occurrence in multiple sclerosis.
Archives of otolaryngology--head & neck surgery 1991;117(5):554-6.
1990: T H Doolittle; Richard H Myers; J R Lehrich; G Birnbaum; William A Sheremata; G M Franklin; Lorene Nelson; Stephen L Hauser
Multiple sclerosis sibling pairs: clustered onset and familial predisposition.
Neurology 1990;40(10):1546-52.
1989: Lawrence Honig; William A Sheremata
Magnetic resonance imaging of spinal cord lesions in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1989;52(4):459-66.
1989: J R Berger; William A Sheremata; L Resnick; S Atherton; Mary Ann Fletcher; Michael D Norenberg
Multiple sclerosis-like illness occurring with human immunodeficiency virus infection.
Neurology 1989;39(3):324-9.
1988: M Judith Donovan Post; L G Tate; Robert M Quencer; G T Hensley; J R Berger; William A Sheremata; G Maul
CT, MR, and pathology in HIV encephalitis and meningitis.
AJR. American journal of roentgenology 1988;151(2):373-80.
1988: Lawrence Honig; R Siddharthan; William A Sheremata; Jerome Sheldon; A Sazant
Multiple sclerosis: correlation of magnetic resonance imaging with cerebrospinal fluid findings.
Journal of neurology, neurosurgery, and psychiatry 1988;51(2):277-80.
1988: Steven Jacobson; V Zaninovic; C Mora; P Rodgers-Johnson; William A Sheremata; C J Gibbs; C Gajdusek; D E McFarlin
Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis.
Annals of neurology 1988;23 Suppl():S196-200.
1987: G C Román; William A Sheremata
Multiple sclerosis (not tropical spastic paraparesis) on Key West, Florida.
Lancet 1987;1(8543):1199.
1987: E DeFreitas; Z Wroblewska; G Maul; William A Sheremata; P Ferrante; E Lavi; M Harper; F di Marzo-Veronese; Hilary Koprowski
HTLV-I infection of cerebrospinal fluid T cells from patients with chronic neurologic disease.
AIDS research and human retroviruses 1987;3(1):19-32.
1986: G H Fisher; N M Garcia; I L Payan; R Cadilla-Perezrios; William A Sheremata; E H Man
D-aspartic acid in purified myelin and myelin basic protein.
Biochemical and biophysical research communications 1986;135(2):683-7.
1985: Hilary Koprowski; E C DeFreitas; M E Harper; M Sandberg-Wollheim; William A Sheremata; M Robert-Guroff; William Saxinger; Mark B Feinberg; F Wong-Staal; Robert C Gallo
Multiple sclerosis and human T-cell lymphotropic retroviruses.
Nature 1985;318(6042):154-60.
1985: Jerome Sheldon; R Siddharthan; J Tobias; William A Sheremata; K Soila; Manuel Viamonte
MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients.
AJR. American journal of roentgenology 1985;145(5):957-64.
1985: William A Sheremata; D C Poskanzer; D G Withum; C L MacLeod; M E Whiteside
Unusual occurrence on a tropical island of multiple sclerosis.
Lancet 1985;2(8455):618.
1984: J R Berger; William A Sheremata; Eldad Melamed
Paroxysmal dystonia as the initial manifestation of multiple sclerosis.
Archives of neurology 1984;41(7):747-50.
1983: J R Berger; W E Rosenfeld; William A Sheremata; Eric C-Y Lian; Doraiswami Ayyar; J Melo; K Kloss
Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody.
Neurology 1983;33(9):1224-6.
1983: J R Berger; William A Sheremata
Persistent neurological deficit precipitated by hot bath test in multiple sclerosis.
JAMA : the journal of the American Medical Association 1983;249(13):1751-3.
1982: J R Berger; William A Sheremata
The hot bath test and multiple sclerosis.
JAMA : the journal of the American Medical Association 1982;247(7):979.
1981: J L Lockhart; G D Webster; William A Sheremata; F A Camuzzi; H C Carrion
Neurogenic bladder dysfunction in the Shy-Drager syndrome.
The Journal of urology 1981;126(1):119-21.
1981: J R Berger; R Ayyar; William A Sheremata
Guillain-Barré syndrome complicating acute hepatitis B. A case with detailed electrophysiological and immunological studies.
Archives of neurology 1981;38(6):366-8.
1981: William A Sheremata; E H Eylar; I Szymanska; A Sazant
Peripheral nerve myelin P2 protein in influenza vaccine.
Transactions of the American Neurological Association 1981;106():221-3.
1980: R E Kelley; R B Daroff; William A Sheremata; J R McCormick
Unusual effects of metrizamide lumbar myelography. Constellation of aseptic meningitis, arachnoiditis, communicating hydrocephalus, and Guillaine-Barré syndrome.
Archives of neurology 1980;37(9):588-9.
1980: D Heffez; William A Sheremata
Experimental embolic stroke in the guinea pig (Cuvis cobaya).
Journal of neuropathology and experimental neurology 1980;39(1):82-7.
1979: William A Sheremata; M A Moscarello; D Lopez
Responses of purified T-cells to mitogens and myelin basic protein in multiple sclerosis.
Transactions of the American Neurological Association 1979;104():103-6.
1978: William A Sheremata; D D Wood; A A Moscarello; J B Cosgrove
Sensitization to myelin basic protein in attacks of multiple sclerosis. A preliminary report.
Journal of the neurological sciences 1978;36(2):165-70.
1978: William A Sheremata; A Sazant; G Watters
Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
Canadian Medical Association journal 1978;118(5):509-13.
1978: William A Sheremata
The role of viruses in the pathogenesis of demyelinative disorder.
Advances in experimental medicine and biology 1978;100():625-6.
1978: William A Sheremata; D D Woods; M A Moscarello
Cellular and humoral responses to myelin basic protein in multiple sclerosis: a dichotomy.
Advances in experimental medicine and biology 1978;100():501-11.
1977: S P Colby-Germinario; William A Sheremata; B Bain; E H Eylar
Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys.
Journal of the neurological sciences 1977;33(1-2):111-29.
1977: William A Sheremata; B Younge; E H Eylar
Retrobulbar neuritis. In vitro evidence of sensitization to myelin basic protein in patients without multiple sclerosis.
Neurology 1977;27(6):557-60.
1977: William A Sheremata; E H Eylar; J B Cosgrove
Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report.
Journal of the neurological sciences 1977;32(2):255-63.
1977: William A Sheremata; H Triller; J B Cosgrove; E H Eylar
Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis.
Canadian Medical Association journal 1977;116(9):985-8.
1977: S P Colby; William A Sheremata; B Bain; E H Eylar
Cellular hypersensitivity in attacks of multiple sclerosis. I. A comparative study of migration inhibitory factor production and lymphoblastic transformation in response to myelin basic protein in multiple sclerosis.
Neurology 1977;27(2):132-9.
1976: J C Allen; William A Sheremata; J B Cosgrove; K Osterland; M Shea
Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis.
Neurology 1976;26(6 PT 1):579-83.
1976: William A Sheremata; J B Cosgrove; E H Eylar
Multiple sclerosis and cell-mediated hypersensitivity to myelin A1 protein.
Journal of the neurological sciences 1976;27(4):413-25.
1976: William A Sheremata; J Allen; A Sazant; J B Cosgrove; K Osterland
Cerebrospinal fluid T & B lymphocyte responses in exacerbations of multiple sclerosis.
Transactions of the American Neurological Association 1976;101():40-5.
1976: William A Sheremata; D D Wood; M A Moscarello
Antimyelin basic protein antibodies and cellular hypersensitivity in multiple sclerosis.
Transactions of the American Neurological Association 1976;101():291-4.
1975: William A Sheremata; S Colby; G Lusky; J B Cosgrove
Cellular hypersensitization to peripheral nervous antigens in the Guillain-Barré syndrome.
Neurology 1975;25(9):833-9.
1975: William A Sheremata; S Colby; Y Karkhanis; E H Eylar
Cellular hypersensitivity to basic myelin (P2) protein in the Guillain-Barré syndrome.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1975;2(2):87-90.
1974: William A Sheremata; J B Cosgrove; E H Eylar
Cellular hypersensitivity to basic myelin (A1) protein and clinical multiple sclerosis.
The New England journal of medicine 1974;291(1):14-7.
1974: William A Sheremata; R E Rocklin; J David
Cellular hypersensitivity in Guillain-Barré syndrome.
Canadian Medical Association journal 1974;110(11):1245-7.
1974: William A Sheremata; R Andrews; D N Pandya
Conduction aphasia from a frontal lobe lesion.
Transactions of the American Neurological Association 1974;99():249-52.
1974: William A Sheremata; J B Cosgrove; E H Eylar
Hypersensitivity to myelin protein preceding attacks of multiple sclerosis.
Transactions of the American Neurological Association 1974;99():177-82.
1973: P O Behan; M W Kies; Robert P Lisak; William A Sheremata; J B Lamarche
Immunologic mechanisms in experimental encephalomyelitis in nonhuman primates.
Archives of neurology 1973;29(1):4-9.
1973: D F Benson; William A Sheremata; R Bouchard; J M Segarra; D Price; N Geschwind
Conduction aphasia. A clinicopathological study.
Archives of neurology 1973;28(5):339-46.
1973: William A Sheremata; P O Behan
Experimental allergic neuritis: a new experimental approach.
Journal of neurology, neurosurgery, and psychiatry 1973;36(1):139-45.
1973: William A Sheremata; J B Cosgrove; P Robb
Cell-mediated hypersensitivity and disease activity in multiple sclerosis.
Transactions of the American Neurological Association 1973;98():306-9.
1972: William A Sheremata; I Sherwin
Alcoholic myelopathy. With spastic urinary bladder.
Diseases of the nervous system 1972;33(2):136-9.
1971: R E Rocklin; William A Sheremata; R G Feldman; M W Kies; J R David
The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens.
The New England journal of medicine 1971;284(15):803-8.
1970: S Podolsky; William A Sheremata
Insulin-dependent diabetes mellitus and Friedreich's ataxia in siblings.
Metabolism: clinical and experimental 1970;19(8):555-61.
1967: William A Sheremata
Reiter's disease. A case with severe and unusual complications.
Medical services journal, Canada 1967;23(10):1216-32.